SOPHIRIS BIO INC. 4/A
4/A · SOPHIRIS BIO INC. · Filed Oct 29, 2013
Insider Transaction Report
Form 4/AAmended
HULME ALLISON
Chief Operating Officer
Transactions
- Award
Common Stock (Right to Buy)
2013-10-25+178,641→ 178,641 totalExercise: $4.41From: 2014-10-25Exp: 2018-10-24→ Common Stock (178,641 underlying)
Footnotes (2)
- [F1]Due to an administrative error, the number of derivative securities acquired was incorrectly shown as 430,375 instead of 178,641.
- [F2]33% of the shares subject to the option shall vest one year after the date of grant. The remainder shall vest monthly thereafter over the next two years until fully vested on October 25, 2016.